![]() Participants described how the use of restrictive take-home dose policies negatively impacted their ability to meet day-to-day responsibilities and also cited the need for daily attendance as a reason for quitting or avoiding OAT. Nearly all of the patients with past or present MMT use were highly critical of the limited access to take-home doses and consequent need for daily or near daily clinic attendance. Interviews explored: reasons for engaging with, or not engaging with MMT how MMT is conceptualized by patients and treatment providers (e.g., as harm reduction or route to abstinence and/or recovery) experiences with MMT perception of barriers to MMT (e.g., organizational/regulatory, social) and how MMT might be improved to support peoples’ substance use treatment needs and goals. This article is based on semi-structured, qualitative interviews with a variety of stakeholders in MMT. In response, this article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general. Yet, MMT’s use of restrictive take-home dose policies that force most patients to attend their clinic on a daily, or near-daily, basis may be unpopular with many patients and lead to low rates of treatment uptake and retention. ![]() ![]() Methadone Maintenance Treatment (MMT) is widely recognized as one of the most effective ways of reducing risk of overdose, arrest, and transmission of blood-borne viruses like HIV and HCV among people that use opioids. ![]()
0 Comments
Leave a Reply. |